Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

Published:2023-06 Issue:6 Volume:5 Page:e341-e350
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Venhoff Nils,Schmidt Wolfgang A,Bergner Raoul,Rech Jürgen,Unger Leonore,Tony Hans-Peter,Finzel Stephanie,Andreica Ioana,Kofler David M,Weiner Stefan M,Lamprecht Peter,Schulze-Koops Hendrik,App Christine,Pournara Effie,Mendelson Meryl H,Sieder Christian,Maricos Meron,Thiel Jens

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference29 articles.

1. Giant cell arteritis;Lazarewicz;BMJ,2019

2. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities;Dejaco;Nat Rev Rheumatol,2017

3. A meta-analysis of the epidemiology of giant cell arteritis across time and space;Li;Arthritis Res Ther,2021

4. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis;Maz;Arthritis Rheumatol,2021

5. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis;Hellmich;Ann Rheum Dis,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6;Rheumatology Science and Practice;2024-09-02

2. The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials;Autoimmunity Reviews;2024-07

3. Current management of giant cell arteritis and its complications;Current Opinion in Rheumatology;2024-06-27

4. The spectrum of giant cell arteritis through a rheumatology lens;Eye;2024-06-19

5. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature;Arthritis Research & Therapy;2024-06-05